Wolfe Research analyst Alex Zukin maintains ZoomInfo Technologies (NASDAQ:ZI) with a Outperform and lowers the price target from $65 to $50.
Analyst Ratings for Viridian Therapeutics
Analysts have provided the following ratings for Viridian Therapeutics (NASDAQ:VRDN) within the last quarter: Bullish Somewhat Bullish Indifferent…